Cannon Global Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-117,990	Closed	-$2.17M	–	76
2024 Q4	$2.17M	Buy	+117,990	New	+$2.17M	4.7%	1